Takao Suzuki Selected Research

Androstenediol

8/2006	Androstenediol administration after trauma-hemorrhage attenuates inflammatory response, reduces organ damage, and improves survival following sepsis.
7/2006	A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage.
4/2006	Androstenediol ameliorates alterations in immune cells cytokine production capacity in a two-hit model of trauma-hemorrhage and sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takao Suzuki Research Topics

Disease

26	Neoplasms (Cancer) 08/2014 - 02/2002
24	Hemorrhage 01/2016 - 01/2006
24	Wounds and Injuries (Trauma) 01/2016 - 01/2006
14	Osteoporosis 11/2020 - 01/2002
9	Hemorrhagic Shock 08/2010 - 01/2006
8	Body Weight (Weight, Body) 01/2021 - 01/2005
8	Cognitive Dysfunction 12/2019 - 02/2005
7	Chronic Disease (Chronic Diseases) 05/2018 - 11/2006
6	Sarcopenia 01/2017 - 11/2008
6	Stomach Neoplasms (Stomach Cancer) 08/2011 - 01/2003
6	Carcinoma (Carcinomatosis) 02/2010 - 04/2002
5	Frailty 01/2021 - 05/2010
5	Pain (Aches) 01/2016 - 03/2003
4	Dementia (Dementias) 10/2018 - 05/2010
4	Type 2 Diabetes Mellitus (MODY) 01/2017 - 01/2008
4	Urinary Incontinence 04/2015 - 08/2004
4	Atrophy 10/2014 - 12/2011
4	Colorectal Neoplasms (Colorectal Cancer) 05/2014 - 11/2008
4	Metabolic Bone Diseases (Osteopenia) 09/2005 - 01/2003
3	Hypertension (High Blood Pressure) 01/2017 - 11/2006
3	Stroke (Strokes) 05/2010 - 01/2005
3	Sepsis (Septicemia) 03/2010 - 04/2006
3	Neoplasm Metastasis (Metastasis) 01/2003 - 01/2002
3	Esophageal Squamous Cell Carcinoma 04/2002 - 01/2002
2	Infections 01/2019 - 01/2002
2	Heart Diseases (Heart Disease) 05/2018 - 01/2011
2	Insulin Resistance 01/2017 - 01/2012
2	Diabetes Mellitus 01/2017 - 11/2006
2	Osteoarthritis 04/2015 - 01/2009
2	Alzheimer Disease (Alzheimer's Disease) 02/2015 - 12/2011
2	Obesity 01/2012 - 12/2009
2	Adenocarcinoma 08/2011 - 05/2010
2	Dyslipidemias (Dyslipidemia) 05/2011 - 01/2005
2	Melanoma (Melanoma, Malignant) 07/2009 - 04/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2008 - 01/2002
2	Glucose Intolerance 01/2008 - 01/2005

Drug/Important Bio-Agent (IBA)

14	Estrogen ReceptorsIBA 07/2008 - 08/2004
13	CytokinesIBA 01/2011 - 04/2006
8	Proteins (Proteins, Gene)FDA Link 01/2011 - 08/2003
8	salicylhydroxamic acid (SHAM)IBA 03/2008 - 04/2006
7	Interleukin-6 (Interleukin 6)IBA 01/2011 - 05/2006
6	Insulin (Novolin)FDA Link 01/2017 - 01/2005
6	Vitamin D FDA LinkGeneric 01/2017 - 09/2003
6	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 01/2003
6	Estrogens (Estrogen)FDA Link 04/2008 - 08/2004
5	Ringer's LactateIBA 08/2010 - 07/2006
5	NAD (NADH)IBA 01/2008 - 05/2006
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2019 - 01/2014
4	Serum AlbuminIBA 11/2017 - 08/2004
4	AntibodiesIBA 08/2013 - 05/2005
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011 - 01/2007
4	Messenger RNA (mRNA)IBA 01/2011 - 09/2003
4	NF-kappa B (NF-kB)IBA 03/2010 - 06/2007
4	LipidsIBA 09/2009 - 10/2007
4	Estrogen Receptor alphaIBA 01/2008 - 08/2006
4	Estradiol (Delestrogen)FDA LinkGeneric 06/2007 - 03/2006
4	Estrogen Receptor betaIBA 09/2006 - 01/2006
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 03/2008
3	AlbuminsIBA 05/2018 - 01/2007
3	Biological ProductsIBA 01/2017 - 10/2006
3	Irinotecan (Camptosar)FDA LinkGeneric 05/2014 - 01/2012
3	Pemetrexed (MTA)FDA Link 10/2012 - 12/2011
3	Pharmaceutical PreparationsIBA 01/2012 - 01/2008
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2011 - 06/2007
3	Keratins (Keratin)IBA 02/2010 - 08/2004
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2009 - 10/2007
3	estradiol-bovine serum albuminIBA 03/2008 - 04/2007
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2007 - 01/2006
3	AndrostenediolIBA 08/2006 - 04/2006
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 04/2007
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 01/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2014 - 08/2013
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2013 - 09/2007
2	SteamIBA 11/2013 - 10/2011
2	ErbB Receptors (EGF Receptor)IBA 08/2013 - 07/2010
2	MineralsIBA 01/2010 - 01/2005
2	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 09/2009 - 04/2009
2	Dual-Specificity PhosphatasesIBA 09/2009 - 04/2009
2	Mitogen-Activated Protein KinasesIBA 04/2009 - 04/2008
2	TensinsIBA 07/2008 - 10/2007
2	Chemotactic FactorsIBA 07/2008 - 09/2007
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2008 - 10/2007
2	Protein Tyrosine PhosphatasesIBA 07/2008 - 10/2007
2	Interleukin-10 (Interleukin 10)IBA 03/2008 - 01/2007
2	Fulvestrant (Faslodex)FDA Link 09/2007 - 06/2007
2	WortmanninIBA 09/2007 - 06/2007
2	Peroxidase (Myeloperoxidase)IBA 09/2007 - 09/2003
2	NitritesIBA 06/2007 - 05/2006
2	NitratesIBA 06/2007 - 05/2006

Therapy/Procedure

17	Activities of Daily Living (ADL) 05/2020 - 01/2004
17	Resuscitation 01/2011 - 03/2006
7	Laparotomy 08/2010 - 03/2006
5	Therapeutics 05/2018 - 05/2011
4	Long-Term Care 01/2021 - 05/2010
4	Drug Therapy (Chemotherapy) 05/2014 - 08/2007
3	Ligation 03/2010 - 04/2006
3	Punctures 03/2010 - 04/2006
3	Gastrectomy 01/2004 - 01/2003